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A Monomeric Membrane Peptide that Lives in Three Worlds: In Solution,
Attached to, and Inserted across Lipid Bilayers
Yana K. Reshetnyak,*y Michael Segala,y Oleg A. Andreev,*y and Donald M. Engelman*
*Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut; and yPhysics Department,
University of Rhode Island, Kingston, Rhode Island
ABSTRACT The membrane peptide pH (low) insertion peptide (pHLIP) lives in three worlds, being soluble in aqueous solution
at pH 7.4, binding to the surface of lipid bilayers, and inserting as a transbilayer helix at low pH. With low pH driving the process,
pHLIP can translocate cargo molecules attached to its C-terminus via a disulﬁde and release them in the cytoplasm of a cell.
Here we examine a key aspect of the mechanism, showing that pHLIP is monomeric in each of its three major states: soluble in
water near neutral pH (state I), bound to the surface of a membrane near neutral pH (state II), and inserted across the mem-
brane as an a-helix at low pH (state III). The peptide does not induce fusion or membrane leakage. The unique properties of
pHLIP made it attractive for the biophysical investigation of membrane protein folding in vitro and for the development of a novel
class of delivery peptides for the transport of therapeutic and diagnostic agents to acidic tissue sites associated with various
pathological processes in vivo.
INTRODUCTION
It has been demonstrated that the initial folding of helical
membrane proteins can be separated into two stages: the for-
mation of independently stable helices across the membrane
lipid bilayer and, then, the interaction of the helices with
each other to form higher order structures (1). For most mem-
brane proteins, additional steps are required for the ﬁnal
equilibration of the native structure (2). Signiﬁcant progress
has been made in understanding protein insertion into mem-
branes, usually catalyzed by the translocon, and the inter-
actions that drive transmembrane helix association (3–6).
Transmembrane helices are commonly identiﬁed in se-
quence data as hydrophobic stretches of;20 amino acids, so
that they are expected to be soluble in the hydrophobic re-
gion of a lipid bilayer and insoluble in water. It was an
unexpected surprise to ﬁnd a peptide that is soluble both in
water and in a bilayer, and that the spontaneous insertion and
folding of a membrane peptide can have signiﬁcant practical
applications.
When we found that the C helix of bacteriorhodopsin can
be soluble at high pH but inserted across a membrane at
lower pH, we thought that it might be used to transport cargo
across membranes (7–8). Subsequently we tested the idea,
and found that the peptide pH (low) insertion peptide
(pHLIP), based on the C helix, can translocate cargo mole-
cules attached to its C-terminus into cells (9–10). Translo-
cation is selective for low pH, and various types of cargo
molecules can be released in the cytoplasm, including organic
compounds, cyclic peptides, and peptide nucleic acids. Fur-
ther, when injected into a mouse, pHLIP accumulates at sites
of acidity, such as tumors, and appears nontoxic (11–12).
Because of its interest on fundamental and practical grounds,
it is important to understand the mechanistic basis of the pep-
tide insertion. In this work, we ask whether the peptide can
function as a monomer, or whether its unusual properties
arise from a cooperative series of self-interaction events. In
earlier work, we found that insertion into lipid bilayers,
human red blood cells, and cancer cells occurs as a result of
protonation of Asp residues located in the transmembrane
part of the peptide due to a decrease of pH (7,11). Proto-
nation induces an increase of peptide hydrophobicity and
triggers insertion of pHLIP into a membrane or bilayer. Here
we present the results of the detailed biophysical character-
ization of pHLIP in solution, in the absence and presence of
liposomes. The data show that pHLIP can act as a monomer,
so its simple insertion mechanism is likely to be well suited
to thermodynamic and kinetic studies of membrane protein
folding in vitro, as well as for the development of drug
delivery and imaging agents.
METHODS
Synthesis of peptides
We have used the following variants of pHLIP sequences:
pHLIP-1: GGEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT,
pHLIP-2: AAEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTCG,
pHLIP-3: ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTG.
All peptides were prepared by solid-phase peptide synthesis using standard
9-ﬂuorenylmethyloxycarbonyl chemistry and puriﬁed by reverse phase
chromatography (on a C18 column) at the W.M. Keck Foundation Bio-
technology Resource Laboratory at Yale University. In a typical preparation
of the soluble form of the peptide, the lyophilized powder was dissolved in a
solution containing 6 M urea and was transferred to working buffer by using
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a G-10 size-exclusion spin column. The concentration of the peptide was
determined by absorbance (e280 ¼ 13,940 M1 cm1).
Conjugation of peptides with ﬂuorescent dyes
Several ﬂuorescent dyes were used in our studies. 4-Chloro-7-nitrobenz-2-
oxa-1,3-diazole (NBD-Cl; Invitrogen, Carlsbad, CA) or 5-carboxytetrame-
thylrhodamine, succinimidyl ester (TAMRA; Invitrogen) were conjugated
with the a-amino group of the N-terminus of pHLIP-1. N,n9-dimethyl-n-
(iodoacetyl)-n9-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine (IANBD;
Invitrogen), and Cy3 or Cy5 maleimide (both dyes were from GE Health-
care, Waukesha, WI) were conjugated with the SH group of the Cys residue
of pHLIP-2 or pHLIP-3. The conjugated peptides were puriﬁed on a G-10
size-exclusion column. The concentration of labeled peptide was determined
by absorbance (NBD-Cl, e336 ¼ 9800 M1 cm1; TAMRA, e555 ¼ 65,000
M1 cm1; IANBD, e478 ¼ 25,000 M1 cm1; Cy3, e549 ¼ 150,000
M1 cm1; and Cy5, e646 ¼ 250,000 M1 cm1). In each case, the labeling
ratio was determined and the concentration of dye never exceeded the
concentration of peptide. In the majority of cases the labeled peptide was
checked by surface-enhanced laser desorption/ionization time-of-ﬂight.
Liposome preparation
Large unilamellar vesicles were prepared by extrusion. 1-Palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC; Avanti Polar Lipids, Alabas-
ter, AL) in chloroform was desolvated on a rotary evaporator and dried under
high vacuum for several hours. The phospholipid ﬁlm was rehydrated in 10
mM phosphate buffer, pH 8.0, vortexed for 2 h, and passed through the
extruder (100 nmmembrane) 15 times. The ﬂuorescent lipids (ﬂuorescent dyes
were conjugated to the headgroups) for fusion experiments were prepared by
mixing of 1 mol % of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n-
(7-nitro-2-1,3-benzoxadiazol-4-yl) (Avanti Polar Lipids) or 1 mol % of 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-n-(lissamine rhodamine B sulfonyl)
(Avanti Polar Lipids) with PC lipids. Large unilamellar vesicles were prepared
by extrusion. The concentration of the ﬂuorescent lipids was determined by
absorbance of ﬂuorescent dyes. The concentration of the nonﬂuorescent lipids
was calculated by measuring of scattered light (excitation and emission at
700 nm and a vertical orientation of the excitation and emission polarizers) on
a PC1 spectroﬂuorometer (ISS, Champaign, ILL). The scattering signal of the
liposomes consisting of nonﬂuorescent lipids were compared with the signal
of a known concentration of liposomes containing 1% phospholipids with
ﬂuorescently labeled headgroups (phosphatidylethanolamine lissamine rho-
damine B) prepared by exactly the same method described above.
To prepare liposomes with 8-aminonaphthalene-1,3,6-trisulfonic acid,
disodium salt (ANTS; Invitrogen) and p-xylene-bis-pyridinium bromide
(DPX; Invitrogen) inside them, the phospholipid ﬁlm was rehydrated in
10 mM phosphate buffer, pH 8.0 containing 12.5 mM ANTS, 45 mM DPX,
and 20 mM NaCl. Untrapped ANTS and DPX were removed from the
solution on a G-25 size-exclusion column and vesicles were transferred into
100 mM NaCl, 10 mM phosphate buffer, pH 8.0. The vesicles were used
immediately after preparation. After two days at 4C they became leaky and
so they were freshly prepared as needed.
Fluorescence and circular
dichroism measurements
Tryptophan ﬂuorescence and circular dichroism (CD) measurements were
carried out on SLM or PC1, ISS spectroﬂuorometers and a Jasco 810 spectro-
polarimeter, respectively (Jasco, Tokyo, Japan) with regulated temperature
control units. After the ﬁrst experiments to establish the self-association
concentration dependence in aqueous solution, the concentration of peptides
used in the study was kept at ,30 mg/mL (or ;7 mM). Tryptophan
ﬂuorescence spectra were recorded at excitation wavelengths of both 280
and 295 nm. For decomposition analysis, we used 295 nm to limit excitation
to the tryptophan ﬂuorophores in the peptide. Fluorescence spectra were
recorded from 300 nm to 450 nm with the spectral widths of excitation and
emission slits set at 2–4 nm and 2 nm, respectively. The polarizers in the
excitation and emission paths were set at the magic angle (54.7 from the
vertical orientation) and vertically (0), respectively, to reduce Wood’s
anomalies from the reﬂecting holographic grating. The emission spectrum of
an aqueous solution of L-tryptophan was used as a standard for the correction
of protein spectra for the instrument spectral sensitivity.
Decomposition of tryptophan
ﬂuorescence spectra
For the decomposition analysis, tryptophan ﬂuorescence spectra of pHLIP
were obtained using excitation at 295 nm in the absence and presence of
POPC vesicles at pH 8.0 and 4.0 and in the presence of increasing con-
centrations of external quencher. We used acrylamide at concentrations of 0,
0.019, 0.038, 0.074, 0.109, 0.142, and 0.206 M as external quenchers of
tryptophan ﬂuorescence. The intensities in ﬂuorescence spectra were cor-
rected for the screening inner ﬁlter effect of this quencher at the excitation
wavelength of 295 nm. The temperature was kept constant at 25C. De-
composition of the tryptophan ﬂuorescence spectra at different quencher
concentrations was performed according to Burstein et al. (13). First, the
ﬂuorescence spectra were converted to the frequency scale from the
wavelength scale, Fn¼ Fl3 l2. Then, the shape of each spectral component
of a protein ﬂuorescence spectrum on the frequency (wavenumber) scale
was approximated by a uniparametric log-normal function,
IðnÞ ¼ Im3 exp  ln2
ln
2
r
3 ln2
a n
a nm
  
ðat n , aÞ
IðnÞ ¼ 0 ðat n$ aÞ
;
8<
:
(1)
where Im is the maximal intensity; n is the current wavenumber; nm is the
spectral maximum position; n and n1 are the positions at half-maximal
amplitudes; r is the band asymmetry parameter, r ¼ ðnm  nÞ=ðn1  nm);
and a is the function limiting point position, a ¼ nm1rðn1 nÞ=ðr2  1Þ:
Therewith, nm, n1, and n are related as (14)
n1 ¼ 0:8313 nm1 7070
n ¼ 1:1773 nm  7780 : (2)
The intensities for the components (Im) were calculated from the set of linear
equations. The shapes and positions of spectral components remain
unchanged with ﬂuorescence quenching by water-soluble quenchers, and
the changes in the intensities of individual components with quenching were
found to obey the Stern-Volmer law. The decomposition was performed
using the simple-ﬁtting-using-mean-square method as a criterion and phase-
plot-based-resolution-using-quenchers algorithms. The spectra were inde-
pendently ﬁtted by one, two, or three components. The typical experimental
noise of ﬂuorescence spectra, which is ;0.5–1.5%, does not permit a sufﬁ-
ciently reliable decomposition for more than three spectral components. The
criterion of attaining the best solution (a sufﬁcient number of components)
was the minimization of root-mean-square differences (residuals) between
theoretical and experimental spectra. For each ith component, the program
output data contained the value of the spectral maximum position (Lmax), the
percent contribution of the component to the area of the total spectrum (F)
and the relative values of the Stern-Volmer constants presented in percent
(100% corresponds to the value of the Stern-Volmer constant for free
tryptophan emission in aqueous solution quenched by acrylamide, which
was taken as 16.8 M1). The Stern-Volmer constants KSV(i) were calculated
as the slopes of linear plots of (Ao/Ac  1) versus quencher concentration,
where Ao and Ac are the areas under the emission component spectra mea-
sured, respectively, in the absence (Ao) and in the presence of quencher at
concentration c (Ac).
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Multiangle laser light scattering
size-exclusion chromatography
Size-exclusion chromatography coupled with on-line laser light scattering,
ultraviolet, and refractive index detection (SEC-LS/UV/RI) was used for the
determination of pHLIP mass in solution. Size-exclusion chromatography
was performed on a Superdex 75 column (Pharmacia, Peapack, NJ) in 10
mM phosphate buffer pH 8.0 containing 100 mM NaCl. The elution proﬁles
were monitored by UV absorption at 280 nm, light scattering at 690 nm, and
differential refractometry. Light scattering and differential refractometry
were carried out using the Mini-Dawn and Optilab instruments (Wyatt Tech-
nology, Santa Barbara, CA). Analysis was carried out as described by Astra
(Astra Software, St. Petersburg, Russia). All data collection and analysis
were performed in the W.M. Keck Foundation Biotechnology Resource
Laboratory at Yale by Dr. Folta-Stogniew.
Sedimentation velocity
Sedimentation velocity experiments were conducted using a Beckman ana-
lytical ultracentrifuge (Fullerton, CA) at 25C in 100 mM NaCl, 10 mM
phosphate buffer, pH 8.0 using absorbance optics at 280 nm wavelength to
visualize the peptide. The sample and buffer volumes were 450 mL. The
peptide concentration was 30 mg/mL in phosphate buffer, pH 8.0. The data
were analyzed using two different programs, SEDFIT and SVEDBERG.
The SEDFIT program provides the distribution of sedimentation coefﬁcients
of noninteracting species, then ﬁtting each distribution with a Gaussian
function. The SVEDBERG program was used to ﬁt the data by using one,
two, and three components. The two-component solution was in very good
agreement with the data obtained by SEDFIT analysis.
Detection of peptide topology
Dithionite (Na2S2O4) chemically quenches the ﬂuorescence of IANBD, and
since the ion does not readily traverse a bilayer, it was used to probe the
topological locations of labels. IANBD groups were conjugated with the SH
groups of Cys residues located on the N- or C-terminus of pHLIP. A 2mMof
labeled peptide was incubated with POPC liposomes (200 lipids per pHLIP)
at neutral pH for 1 h, and then insertion was triggered by reducing the pH to
4.0. Changes in the ﬂuorescence signal of IANBDwere monitored at 550 nm
(excited at 478 nm) upon addition of 12 mM of dithionite in phosphate
buffer pH 5.0 (ﬁnal concentration in cuvette ¼ 1–2 mM). At the end of the
experiment, vesicles were disrupted by Triton-100 to allow access of di-
thionite to all IANBD groups. As controls, dithionite (in phosphate buffer
pH 8.0) was added to each peptide labeled on the N- or C-terminus in the
absence and presence of POPC liposomes at pH 8.0, and immediate
quenching of IANBD ﬂuorescence was observed. Fresh dithionite solution
was prepared for each experiment.
Membrane leakage
The POPC liposomes were loaded with the ﬂuorescent dye ANTS and its
quencher, DPX. Upon the disruption of liposomes, both molecules come out
and dilution induces a decrease of the quenching of ANTS ﬂuorescence by
DPX, so the increase in ﬂuorescence signal reports any process of liposome
destabilization. The ﬂuorescence was recorded at 495 nm with excitation at
350 nm. The temperature was kept at 25C. First, the emission signal was
recorded for POPC containing ANTS and DPX in phosphate buffer pH 8.0,
then peptide was added followed by a drop of the pH to 5.0–4.0 by addition
of HCl, and at the end of the experiment vesicles were disrupted by deter-
gent. After each step the changes of ﬂuorescence signal was monitored dur-
ing 10–20 min. The experiment was performed over a wide range of peptide/
lipid molar ratios: 0.001, 0.002, 0.004, 0.02, and 0.1 at a maximum peptide
concentration of 10 mM. Only freshly prepared liposomes loaded with
ANTS and DPX were used in the experiments.
Fusion assay
The fusion assay is based on energy transfer from NDB to rhodamine. POPC
liposomes containing 1 mol % of NDB or rhodamine were prepared. The
ﬂuorescence was excited at 450 nm and emission was recorded from 480 to
620 nm. Vesicles containing NBD and rhodamine ﬂuorophores were mixed
with nonﬂuorescent POPC in the absence (as a control) and presence of
pHLIP and the changes in ﬂuorescence signal at 593 nm were recorded
immediately, 1, 3, and 20 h later. Then, fusion was initiated by several
freeze-thaw cycles after 20 h. Signiﬁcant energy transfer from NDB to
rhodamine occurred only after freeze-thaw cycles. The experiment was
performed at two peptide/lipid molar ratios—0.004 and 0.008. The results in
both cases were similar.
Oligomerization (Fo¨rster resonance energy
transfer assay)
Oligomerization was monitored by Fo¨rster resonance energy transfer
(FRET) using two donor-acceptor pairs: NDB-TAMRA and Cy3-Cy5.
Donor and acceptor dyes were each conjugated to the N-terminal regions of
pHLIP peptides. NDB and TAMRA ﬂuorescent dyes were attached to the
a-amino group of the N-terminus, while Cy3 and Cy5 were conjugated with
the SH group of Cys included at the N-terminus of the peptide. The labeling
ratio was determined by absorption at 280 nm and at the absorption wave-
lengths of the dyes (see section above). Several samples were prepared with
increasing concentration of acceptor (from 0 to 1.2 mM). In all samples the
total concentration of peptide was kept constant (,30 mg/mL) by the addi-
tion of nonlabeled peptide. In all samples the total concentration of lipids
was kept constant and all measurements were carried out at peptide/lipid
ratios of 0.013 and 0.0033. In the case of NDB-TAMRA, the samples were
excited at 450 nm and emission was recorded over the 480–630 nm spectral
range. In the case of Cy3-Cy5, the samples were excited at 500 nm and
emission was recorded over the 540–800 nm spectral range. All measure-
ments were performed in phosphate buffer at pH 8.0 or pH 4.0 at constant
temperature (25C). The efﬁciency of energy transfer (E) was measured by
the decrease of donor ﬂuorescence according to the standard equation
E ¼ 1 FDA
FD
;
where FD and FDA are the ﬂuorescence intensity of the donor in the absence
and presence of acceptor, respectively. Experimentally measured efﬁciency
of energy transfer was compared with theoretically predicted values cal-
culated from the Wolber-Hudson equation (15). Both donor-acceptor pairs
have similar Fo¨rster distances, ;55 A˚.
RESULTS
The pHLIP peptide exhibits three characteristic states: state I,
soluble in water near neutral pH; state II, bound to the sur-
face of a membrane near neutral pH; and state III, inserted
across the membrane as an a-helix at acidic pH (Fig. 1)
(7,11). The major goal of our study is to establish the oligo-
meric state and conformation of the peptide in each of these
states. We ﬁrst studied pHLIP in solution at pH 8.0 in the
absence of liposomes. Size-exclusion chromatography cou-
pled with on-line laser light scattering, ultraviolet, and re-
fractive index detection (SEC-LS/UV/RI) was used to probe
the peptide behavior in solution. Table 1 and Fig. 2, a and b,
present the data for various concentrations of pHLIP. Over a
wide range of concentrations from 36 to 170 mg/mL pHLIP
eluted in the form of a tetramer (16.4 6 0.7 kDa). The
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molecular mass of pHLIP used in the experiment was 4.1
kDa. However, we noticed that the amount of peptide after
the column was always much less than expected, and we
suspected that low-molecular-mass species might exist, but
they might interact with column, since the peptide sequence
contains many hydrophobic residues.
We then applied spectroscopic approaches: ﬂuorescence
and circular dichroism (CD) spectroscopy to reveal oligo-
meric states of pHLIP in solution. Measurements of the tryp-
tophan ﬂuorescence (pHLIP has two tryptophan residues) and
CD signals were performed over a wide range of concentra-
tions (Fig. 2, c and d). Interestingly, we observed the CD
spectrum characteristic of an exciton, with a minimum at 232
nm (16,17). Such an exciton could be formed as the result of
the stacking of aromatic amino acids due to peptide aggre-
gation. Further, the position of the tryptophan ﬂuorescence
maximum was 341 nm, reporting tryptophan residues par-
tially buried in the protein interior (18). Dilution of pHLIP led
to the disappearance of the CD exciton peak and a shift of
the tryptophan emission maximum to 348 nm, which reﬂects
the complete exposure of tryptophan residues towater (19). The
data indicate that the pHLIP tetramer dissociates with de-
creasing concentration, and the dissociation curves obtained
from the CD and ﬂuorescence measurements are very similar
(Fig. 2 e). At concentrations,30–35mg/mL, the dissociation
is completed.
What is the oligomeric state of pHLIP in solution at con-
centrations ,30–35 mg/ml? We applied the method of
decomposing the tryptophan ﬂuorescence spectra into log-
normal spectral components, which can be assigned to indi-
vidual tryptophan residues (13,18). The decomposition
method is based on use of additional information, which
allows our reducing the complexity of the system and ﬁnding
a stable solution. Particularly, the spectrum of an elementary
spectral component on the frequency scale is described by a
four-parametric log-normal function. The special experi-
mental study of dependence between position of maximum
and width of ﬂuorescence spectra allowed us to reduce the
number of unknown parameters from 4 to 2 (14). The use of
an asymmetric log-normal function for the ﬁtting of spectral
signals has proved to be very successful in assessing the
contributions of multiple tryptophans (20,21). The stability
of solution is also enhanced by including the analysis set of
ﬂuorescence spectra measured at various concentrations of
external quenchers of tryptophan ﬂuorescence (the shape and
position of spectral components should be unchanged during
quenching, while the intensity is changed according to the
Stern-Volmer law). The method of decomposing protein
ﬂuorescence into spectral components has been effectively
applied to reveal heterogeneity in the spectral properties of
tryptophan ﬂuorophores arising from heterogeneity in the
environments of tryptophan residues in proteins (22–24).
Recently, additional supportive evidence of the accuracy of
the decomposition algorithms was obtained through the
analysis of the correlation of the experimental spectra of
single-tryptophan-containing mutants of multi-tryptophan
proteins OEP16 (22) and ECP (24).
The decomposition analysis was applied to pHLIP using a
series of tryptophan ﬂuorescence spectra measured at various
concentrations of acrylamide as an external quencher. The
positions of spectral maxima, their contributions to the total
intensity, and the relative values of the Stern-Volmer con-
stants obtained as a result of decomposition analysis of a
series of tryptophan ﬂuorescence spectra of 30 mg/mL of
pHLIP in phosphate buffer, pH 8.0 are presented in Table 2.
One-hundred percent corresponds to the value of the
FIGURE 1 The three major states of pHLIP at concen-
tration of , 30 mg/mL are illustrated: soluble in water at
pH . 7 (State I), bound to the surface of a lipid bilayer at
the same pH and at a lipid/peptide molar ratio. 100 (State
II), and inserted across the bilayer as an a-helix at low pH
(State III).
TABLE 1 pHLIP in solution studied by size exclusion chromatography coupled with on-line laser light scattering, ultraviolet and
refractive index detection; a predominant peak corresponding to a pHLIP tetramer was observed in each case
Concentration in
the injected sample (mg/ml)
Concentration at
maximum (mg/ml)
Peak elution at
UV trace (ml)
Molecular mass (kDa) averaged
for the entire peak
Molecular mass (kDa) average
from maximum
700 169 10.81 16.7 16.8
560 62 10.83 17.1 17.1
420 48 10.82 16.0 15.9
280 36 10.83 15.9 15.7
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Stern-Volmer constant for free tryptophan emission in
aqueous solution quenched by acrylamide, which was taken
as 16.8 M1. Two spectral components were identiﬁed. The
short-wavelength component makes a small contribution
(9.56 3.7%) in total intensity. However, the second compo-
nent, which exhibits emission at 349.1 nm with 81.8% acces-
sibility to acrylamide, corresponds to the tryptophan residues
fully exposed to solvent.
The ﬂuorescence data indicate that tryptophan residues are
accessible to water molecules; however, we cannot exclude
the possibility of the formation of low-order oligomers in
which the tryptophan residues are completely exposed to
water. Therefore, we used analytical ultracentrifugation to
perform sedimentation velocity runswith 30mg/mLof pHLIP
in phosphate buffer, pH 8.0. Analysis of the distribution of
sedimentation coefﬁcients using the SEDFIT program gave
two components (Fig. 2 f). The ﬁtting of the distribution of
sedimentation coefﬁcients by Gaussian functions gave a pre-
dominant component (94%) with a sedimentation coefﬁcient
of 0.736 0.14 and amolecular mass of 3.846 1.02 kDa. The
second component made a small contribution (6%), and
corresponded to the pHLIP tetramer (18.6 6 13.0 kDa). The
data were also analyzed by using the SVEDBERG program.
The data were ﬁtted using the modiﬁed Fujita-MacCosham
function. The result of ﬁtting shows a predominant component
with sedimentation coefﬁcient equal to 0.79 (95% conﬁdence
interval equals 0.79–0.80) and corresponding to a molecular
mass of 3.98 kDa (95% conﬁdence interval, 3.86–4.36 kDa)
and the RMS of ﬁtting was 1.4 3 102. Both methods give
very similar results: the existence of one predominant species
with a molecular mass of 3.8–4.0 kDa that matches the molec-
ular mass of monomeric pHLIP (4.05 kDa). Thus, all our data
indicate that pHLIP is a monomer (at least 94% of the peptide)
in solution at pH 8.0 and a concentration of,30 mg/ml.
To understand the mechanistic and practical aspects of
pHLIP, it is important to establish the range of concentrations
FIGURE 2 pHLIP mass in solution at pH 8.0
studied by size-exclusion chromatography cou-
pled with on-line laser light scattering, ultravi-
olet, and refractive index detection. (a) The UV
and RI signals of the major fraction from
the column. (b) The results of SEC-LS/UV/RI
analysis revealed that the major fraction from
the column contained tetrameric pHLIP. Nor-
malized ﬂuorescence (c) and CD (d) spectra of
various concentrations of pHLIP measured in
10 mM phosphate buffer, pH 8.0. The emission
spectra were measured at an excitation wave-
length of 295 nm. The spectral maximum shifts
from 341 to 348 upon dilution. At high peptide
concentration, the CD spectra have a charac-
teristic exciton pattern (minimum at 232 nm),
which disappears at low concentration where
the peptide adopts a random conﬁguration. (e)
The pHLIP concentration dependence in solu-
tion of the ﬂuorescence maximum (red point
and line) and the 232:126 nm ratio of the CD
signal (black point and line). (f) The distribu-
tion of sedimentation coefﬁcients (black line)
obtained by analysis of sedimentation velocity
runs obtained for 30 mg/mL of pHLIP in 10
mM phosphate buffer, 100 mM NaCl, pH 8.0
using the SEDFIT program. The distribution
was ﬁtted by Gaussian functions and two com-
ponents were revealed (the theoretical line is
red, the components are green and blue). One
predominant component was found, correspond-
ing to a peptide molecular mass of 3.84 kDa
(molecular mass of the peptide is 4.1 kDa).
Similar results were obtained by applying the
SVEDBERG program (see text).
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where pHLIP exists in a monomeric form in solution. Our
previous studies showed that, at pH 7.4–8.0, the peptide
interacts with a lipid bilayer and does not exhibit any ele-
ments of secondary structure; it binds weakly to the surface
without insertion. A decrease of pH induces insertion of
pHLIP and the formation of a stable transmembrane a-helix.
Attachment and insertion can be monitored by changes of
CD and ﬂuorescence signals (Fig. 3, a and b). The process of
insertion is fully reversible, increasing the pH leads to loss
of helical structure and release of pHLIP from the membrane.
At pH, 5.0, pHLIP has a tendency to aggregate (short wave-
length shift of maximum position of tryptophan spectrum)
with the formation of partial helical structure. The behavior of
pHLIP at 25C and 37C was identical, except for a decreased
amount of helicity for pHLIP in solution at low pH at elevated
temperature versus lower temperature (data not shown).
To examine whether fusion or leakage of liposomes is
promoted or induced by pHLIP, we used standard Fo¨rster
resonance energy transfer (FRET) assays. Fluorescently-
labeled lipidswere used to prepare two populations of vesicles
containing NBD or rhodamine ﬂuorophores. NBD and rho-
damine form a good donor-acceptor pair, and any fusion of
liposomes would induce mixing of lipids and enhance energy
transfer from NBD to rhodamine (25). The liposomes were
mixed in the absence (as a control) and presence of 25mg/mL
of pHLIP at pH 8.0 and 4.0, at peptide/lipid ratios of 0.004
and 0.008. The rhodamine ﬂuorescence was measured to
monitor a possible fusion immediately after mixing, 1, 3, and
20 h later (Fig. 3 c). We observed no signiﬁcant ﬂuorescence
increase of rhodamine in the presence of peptide. As a sec-
ondary control experiment, we subjected the same vesicles to
multiple freeze-thaw cycles to induce liposome fusion. In that
case we observed a signiﬁcant increase of rhodamine ﬂuo-
rescence due to energy transfer fromNBD.We concluded that
pHLIP does not induce fusion at either normal or low pH in
the studied concentration range.
To probe the ability of pHLIP to induce leakage of
liposomes we used a standard ANTS-DPX ﬂuorescence
assay. The assay is based on the ability of DPX to quench the
ﬂuorescence from ANTS when both are trapped inside vesi-
cles. Disruption of liposomes leads to the release of mole-
cules and enhancement of ﬂuorescence signal of ANTS (26).
The leakage experiments were performed for a range of
peptide: lipid ratios of 0.001, 0.002, 0.004, 0.02, and 0.1 at a
maximal peptide concentration of 10 mM. We observed no
leakage of liposomes in presence of pHLIP at normal and
low pH for various peptide/lipid ratios until the vesicles were
disrupted by detergent. Only at a 1:10 peptide/lipid ratio, a
very high concentration of peptide relative to lipids, was a
gradual leakage observed at pH 8.0.
We next examined pHLIP on the surface of and inserted
into lipid bilayers. We used the decomposition analysis (see
above) of pHLIP in the presence of liposomes at pH 8.0 and
4.0 (Table 2). At pH 8.0, when pHLIP is attached to a lipid
bilayer surface, we detected two components of the trypto-
phan ﬂuorescence spectra measured at various concentrations
of acrylamide. The long-wavelength component corresponds
to a tryptophan residue exposed to water molecules, while
the short-wavelength component indicates that one of the
tryptophan residues is buried in the hydrophobic environ-
ment. A two-component solution was also found for pHLIP
inserted across the lipid bilayer at pH 4.0; however, both
components were shifted to short wavelengths with reduced
accessibility of tryptophan to acrylamide. At low pH, the
ﬁrst and second components are consistent with one tryp-
tophan residue buried deeply in the lipid bilayer and a
second located at the interface between aqueous environ-
ment and lipid headgroups. These results correlate well with
the position of the C helix in the crystal structure of bac-
teriorhodopsin, which show that one tryptophan of the C
helix is located practically in the middle of the hydrophobic
core of the membrane, while the other tryptophan is at the
level of the headgroups. The quantum yield of the emission
of the short-wavelength component might be reduced by
contact of the indole ring atoms of tryptophan with the OH
group of Tyr and side-chain nitrogen atoms of Arg (Fig.
2 d), which are known to be good quenchers of tryptophan
emission (27).
One of the simplest methods to detect oligomerization
of peptides is to study the dependence of the ﬂuorescence
maximum of a tryptophan residue located in the hydrophobic
core on lipid concentration, since increasing the concentra-
tion of lipids should lead to a blue shift of tryptophan emis-
sion due to a dissociation of any peptide oligomers (28). We
did not observe any changes in the position or shape of the
ﬂuorescence spectra of pHLIP over a wide range of POPC
concentrations. However, these experiments cannot rule out
completely the possibility of oligomers.
To further test for oligomers, we used FRET. Since energy
transfer results even from random colocalization of donor
and acceptors in a lipid bilayer, we needed to compare the
experimental data of energy transfer with that theoretically
predicted for the selected donor-acceptor pairs. To calculate
TABLE 2 Decomposition of pHLIP tryptophan ﬂuorescence
spectra in the absence and presence of POPC liposomes at
pH values 8.0 and 4.0
Lmax, nm F, % Ksv, %
pHLIP, pH8.0 325.0 6 1.2 9.5 6 3.7 18.1 6 7.8
349.1 6 0.5 90.5 6 3.7 81.8 6 0.8
pHLIP 1 POPC, pH8.0 326.4 6 1.1 39.4 6 3.0 16.1 6 1.7
347.4 6 1.5 60.6 6 3.0 80.1 6 5.1
pHLIP 1 POPC, pH4.0 321.8 6 4.2 21.6 6 1.0 9.9 6 1.7
339.1 6 4.6 78.4 6 1.8 20.4 6 1.9
The table contains the parameters of log-normal spectral components: the
position of each spectral maximum (Lmax, nm), the total intensity contribution
of each component (F, %), and the relative Stern-Volmer constant (Ksv, %,
where 100% corresponds to the value of the Stern-Volmer constant for free
tryptophan emission quenched by acrylamide in aqueous solution, which was
taken as 16.8 M1).
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the values of energy transfer we need to know the topology
of pHLIP insertion into the lipid bilayer. In our previous
work we used the membrane-impermeable dithionite ion
(S2O
2
4 ), which can chemically modify the NBD ﬂuoro-
phore and quench its ﬂuorescence (29), to examine the
position of peptide N-terminus labeled with NBD (9). The re-
sults indicated that the N-terminus stays outside while the
C-terminus of the peptide is translocated across the bilayer.
FIGURE 3 Tryptophan ﬂuorescence (a) and
CD (b) spectra of 30 mg/mL pHLIP in 10 mM
phosphate buffer in the absence and presence of
POPC liposomes at various pHs. The ﬂuores-
cence and CD spectra of pHLIP at pH 8.0 (black
solid line) indicate a random conﬁguration with
tryptophan residues fully exposed to solvent.
However, at low pH (pH 3.5) (black dotted line)
the peptide tends to aggregate, leading to a shift
of position of the ﬂuorescence maximum and
the appearance of some elements of secondary
structure. Incubation of pHLIP with the POPC
liposomes at pH 8.0 (blue solid line) induces the
burial of tryptophan residues inside the lipid
bilayer without helix formation. Decreasing the
pH to 4.0 by the addition of HCl (red solid line)
induces the insertion of pHLIP and the formation
of helix. When POPC vesicles were added to
the pHLIP at pH 3.5 there was an increase of
ﬂuorescence, a shift of the spectrum to short
wavelengths, and an enhancementof helicity (red
dotted line). The insertion of pHLIP across the
lipid bilayer is a reversible process; an increase of
pH leads to a loss of helicity and the release of the
peptide from themembrane (green solid line). (c)
The ability of pHLIP to induce vesicle fusionwas
tested on amixture of two populations of vesicles
with NDB and rhodamine ﬂuorescently-labeled
lipids. The graph presents the changes of rhoda-
mine ﬂuorescent signal during incubation of
labeled vesicles in the presence of pHLIP at pH
8.0 and 4.0. The values were normalized to the
rhodamine ﬂuorescence (at 593 nm, excited at
450 nm) recorded after mixing of NDB-labeled
liposomes with rhodamine-labeled liposomes in
the absence of pHLIP. A signiﬁcant increase of
emission signal was observed only after several
freeze-thaw cycles, which led to the fusion of
vesicles. (d) An atomic representation of pHLIP
taken from the crystal structure 1C3W (the C
helix of bacteriorhodopsin) was generated by
RasWin Molecular Graphics 2.6. The green are
tryptophan residues. (e) The topology of pHLIP
in a lipid bilayer was determined using the
IANBD-dithionite quenching reaction. The ﬂuo-
rescence signal of IANBD attached to an SH
group at the N-terminus (IANBD-pHLIP) or
C-terminus (pHLIP-IANBD) of the peptide was
monitored at 550 nm (excited at 478 nm). The
starting point is a signal of IANBD-pHLIP and
pHLIP-IANDB incubated with POPC followed
by lowering the pH to 4.0. Then, dithionite was
added. In case of IANBD conjugated to the
C-terminus no change of signal is observed (black line), while the ﬂuorescence of IANBD conjugated to theN-terminus of peptide is completely quenched (red line).
The data indicate that the N-terminus of pHLIP stays outside, but that the C-terminus of pHLIP goes inside of the vesicles. (f) The pHLIP oligomeric state in a lipid
bilayerwas studied byFRET.TheN-terminus of pHLIPwas conjugated eitherwithNDBorTAMRA.Fluorescence spectra ofNDBweremeasured in thepresence of
an increasing concentrationofTAMRA-pHLIPwhile keeping the total peptide and lipid concentration constant. (g) The comparison of calculated efﬁciencyof energy
transfer for NDB-TAMRA (blue points) and Cy3-Cy5 (red points) pairs with the theoretically predicted efﬁciency of energy transfer (black line) calculated from the
Wolber-Hudson equation for noninteracting molecules.
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Further, cargo molecules attached to the C-terminus were
successfully translocated by pHLIP into the cytoplasm,
which is consistent with the topology experiments. How-
ever, there is the possibility that conjugation of the peptide
C-terminus with dye might prevent insertion of this-terminus
across the membrane. Since proper topology of insertion is
essential for the FRET experiments we repeated the exper-
iments with IANBD that is an analog of NBD designed for
conjugation with Cys residues. IANBD was conjugated with
a Cys residue placed on the N- or C-termini of the pHLIP.
The peptides labeled with IANBD were incubated with
POPC liposomes and the pHwas dropped to pH4.0 to induce
peptide insertion. Addition of dithionite ion did not lead
to the quenching of IANBD ﬂuorescence in case of the
C-terminus labeling (Fig. 3 e), while the ﬂuorescence of dye
conjugated with the N-terminus of pHLIP was completely
quenched by addition of dithionite. As a control experiment,
dithionite was used to quench emission of IANBD conjugated
with the N- and C-termini of pHLIP in the absence and pres-
ence of POPC at pH 8.0 (when the peptide is not inserted), and
we observed immediate quenching of the IANBD ﬂuores-
cence after addition of dithionite. Thus, pHLIP labeling with
IANBD does not prevent peptide insertion across the bilayer:
insertion is unidirectional; the C-terminus of pHLIP goes
through the lipid bilayer, while the N-terminus stays outside.
For FRET experiments we used a NBD-rhodamine
(TAMRA) donor-acceptor pair with a nominal Fo¨rster dis-
tance (R0) of 55 A˚. These dyes have been successfully used
to probe oligomerization of other peptides in membranes
(30). NBD and TAMRA were attached to the a-amino group
of the N-terminus of pHLIP (there are no Lys residues in
pHLIP). Several samples were prepared separately, with var-
ious concentrations of acceptor and a ﬁxed concentration of
donor. Peptide/lipid ratios were 0.013 and 0.0033, and
unlabeled pHLIP was added to each sample to keep the total
peptide concentration constant. After incubation of labeled
and unlabeled pHLIP with the liposomes, the pH was
dropped to 4.0 and ﬂuorescence measurements were per-
formed. The efﬁciency of energy transfer was monitored by
the decrease in the ﬂuorescence signal of the donor, NBD
(Fig. 3 f). The measured efﬁciency of energy transfer as a
function of acceptor concentration (Fig. 3 g) coincides with
the theoretical values calculated from the Wolber-Hudson
equation (15), indicating an absence of oligomers. We re-
peated the experiments with the Cy3-Cy5 donor-acceptor
pair to exclude the possibility of donor self-quenching. It is
known that self-quenching is minimal for the Cy3 dye (31).
Using the Cy3-Cy5 pair, we observed nothing more than
random colocalization of dyes in the lipid bilayer, implying an
absence of oligomerization of the inserted pHLIP (Fig. 3 g).
We also performed FRET experiments with both donor-
acceptor pairs described above at pH 8.0, when the peptide is
attached to the surface of the membrane, and obtained the
same behavior of energy transfer efﬁciency (data not shown).
We conclude that dyes conjugated with the N-terminus of
pHLIP are.60–80 A˚ from each other when pHLIP interacts
with the membrane at pH 8.
DISCUSSION
The folding of membrane proteins is facilitated by complex
molecular machines in vivo, including the translocon that
places most transmembrane helices across the bilayer (32,33).
The study of the insertion of helices in vitro is a problem that
has been vexed by the insolubility of the helices in water and
their strong aggregation tendencies. Attempts have been
made to design synthetic peptides that are soluble in aqueous
solution, and that spontaneously insert into the membrane
(34). Peptides capable of spontaneous insertion into lipid
bilayers are attracting attention because of the recent ﬁnding
that moderately polar transmembrane domains with se-
quences of up to 85 residues can posttranslationally translocate
themselves into membranes in a translocon-defective yeast
strain, in contrast to more hydrophobic sequences that cannot
(35,36). Also, spontaneous insertion could open an opportu-
nity to translocate cargo molecules through the cell mem-
brane into the cytoplasm (9), or to interact with membrane
proteins to inﬂuence their activities. pHLIP is an example of
a peptide that has three major states: soluble in water (state I),
bound to the surface of a membrane (state II), and inserted
across the membrane as an a-helix (state III) (see Fig. 1).
Based on the studies reported here, we now know that the
peptide is monomeric in all three states, establishing that a
class of molecules exists with the properties needed for
membrane folding and insertion studies in vitro.
We applied a variety of biophysical techniques to study the
three states of the peptide. We found that, in solution, pHLIP
exists as a monomer at concentrations ,30 mg/mL (;7.3
mM) or less. All further experiments were performed at con-
centrations of pHLIP , 30 mg/mL. Before investigating the
oligomeric state of pHLIP in the presence of lipid vesicles,
we conﬁrmed that the peptide does not induce vesicle fusion
or leakage at the experimental pH values. Various ﬂuores-
cencemethods were applied, and it was found that the peptide
is a monomer inserted across a lipid bilayer and in its surface
interaction mode. The results obtained are in a very good
agreement with the experiments carried out on HeLa and
human red blood cells, where an absence of cell toxicity and
leakage was found in the presence of pHLIP (9–11). These
and other data (see (9)) ruled out the possibility of pore
formation as a mechanism of molecular translocation through
the membrane by pHLIP.
pHLIP possesses properties that are well suited for the
thermodynamic and kinetic investigation of insertion and
folding of membrane peptides, since the peptide is soluble in
aqueous solution and monomeric in all three major states.
pHLIP constitutes the ﬁrst example of the use of the insertion
and folding of a monomeric membrane peptide to translocate
cargo molecules through the lipid bilayer of a cell membrane.
Thus, fundamental studies of membrane protein folding have
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led to potentially important practical applications. We dem-
onstrated in vivo that pHLIP can target acidic solid tumors
and inﬂammatory arthritis with high accuracy (11) and
translocate through the lipid bilayer and release cargo
molecules in the cytoplasms of cells with an elevated level
of extracellular acidity (9). All experiments with cargo mole-
cule translocation into live cells by pHLIP were performed at
peptide concentrations of 0.5–2.0 mM, which is much lower
than the 7–8 mM limit for remaining monomeric. A con-
centration range of 0.5–4 mM to target sites of disease also is
also realistic for in vivo experiments. Therefore, the ﬁndings
presented in this article have signiﬁcance both for funda-
mental and applied studies. We believe that pHLIP opens the
opportunity to reveal the major physical principles of mem-
brane protein folding using a simple model system and also
enables the design of a new class of agents for targeting
therapeutic and diagnostic agents to tissues with low extra-
cellular pH, such as those associated with a variety of patho-
logical processes.
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